http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2560725-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24aca9ded2638ea793d05360dde7a4a0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H10N10-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H10K71-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H10K71-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H10N10-856
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H01L51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/H01L35-24
filingDate 2017-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5dd3d44fdf953783fd9f40d80ee68ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05f8a9c92a79ca69203594a2ca8ab393
publicationDate 2018-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-2560725-A
titleOfInvention Ink formulation
abstract A formulation comprising a fullerene and an n-dopant dissolved or dispersed in a solvent mixture comprising a first aprotic solvent and a second aprotic solvent. The solvent mixture having a polar Hansen solubility parameter δP of at least 4.0. The formulation may be used in forming a layer of a thermoelectric device, for example by printing of the ink formulation into wells 107 defined by a patterned insulating layer over an electrode 103 to form the n-type leg 109 of a thermoelectric device. The n doped fullerene may be n-doped PCBM, and the dopant may be a 1-H-benzimidazole. The formulation may be dispersed or dissolved in a polymer binder. The first aprotic solvent may be selected from the group consisting of benzene substituted with one or more substituents. The second solvent may be selected form the group consisting of dimethylformamide, dimethylsulfoxide, N-methylpyrrolidone or propylene carbonate.
priorityDate 2017-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012054504-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011127075-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559219
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412478856
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13387
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10326
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419511497
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID679
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67505
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490115
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408971381
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419539004
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415736955
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545853
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520276
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7247
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID241
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409283606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15745046
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7924
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415946743
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516778
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558806
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6228
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID346011
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415741171
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9229

Total number of triples: 49.